Literature DB >> 9618693

Cutaneous T-cell lymphoma with intracerebral and bilateral intraocular spread.

E L Wylen1, R B Williams, A Nanda.   

Abstract

Brain metastasis from systemic or cutaneous lymphoma is infrequently encountered. We present a case report of cutaneous T-cell lymphoma (CTCL) that metastasized to the brain. A literature review identified fourteen other cases of brain infiltration with CTCL. This report focuses attention on the typical presentation and markedly poor prognosis that characterize this rare problem. It also emphasizes the suspicion with which a brain mass in a lymphoma patient with neurological changes should be regarded.

Entities:  

Mesh:

Year:  1998        PMID: 9618693     DOI: 10.1080/01616412.1998.11740523

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  4 in total

1.  T cell receptor gamma-chain gene polymerase chain reaction to diagnose central nervous system involvement by cutaneous T cell lymphoma.

Authors:  Robert Taylor; Jo-Anne Vergilio; Michael Shapiro; David Raizen; Jennifer Hunt; Cindy McGrath; Alain Rook; Adam Bagg
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

Review 2.  Primary intraocular lymphoma of T-cell type: report of a case and review of the literature.

Authors:  Sarah E Coupland; Gerasimos Anastassiou; Norbert Bornfeld; Michael Hummel; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

Review 3.  Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features.

Authors:  Sarah E Coupland; Heinrich Heimann; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-29       Impact factor: 3.117

4.  Ophthalmic manifestations, cytology, immunohistochemistry, and molecular analysis of intraocular metastatic T-cell lymphoma: report of a case and review of the literature.

Authors:  Grace A Levy-Clarke; David Greenman; Pamela C Sieving; Gordon Byrnes; Defen Shen; Robert Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2008 May-Jun       Impact factor: 6.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.